Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CPN1 | P15169 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.39 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.38 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667322 | 0.81 | CYP2C19 (0.62) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL17730949 | 0.81 | CYP2C19 (0.62) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL17730952 | 0.81 | CYP2C19 (0.62) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL3253008 | 0.80 | CYP2C19 (0.61) | CYP2C19CYP2D6LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL3253010 | 0.80 | CYP2C19 (0.61) | CYP2C19CYP2D6LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL6907407 | 0.80 | CYP2C19 (0.61) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL3308217 | 0.79 | CYP2C19 (0.69) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL11334281 | 0.79 | CYP2C19 (0.69) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL3269453 | 0.77 | CYP2C19 (0.57) | CYP2C19POLBEPHX1CYP2D6SRC | |
| SCHEMBL1458057 | 0.77 | CYP2C19 (1.00) | CYP2C19POLBEPHX1CYP2D6SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124542-A1 | GDF11 VARIANTS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-04-18 | — | — | US | disclosed |
| EP-3881859-B1 | COMPOSITIONS FOR INCREASING NEUROGENESIS AND ANGIOGENESIS | HARVARD COLLEGE (US) | 2024-03-06 | — | — | EP | disclosed |
| US-11725033-B2 | GDF11 variants and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230241171-A1 | USE OF GDF11 TO DIAGNOSE AND TREAT ANXIETY AND DEPRESSION | INSTITUT PASTEUR (FR) | 2023-08-03 | — | — | US | disclosed |
| EP-4179333-A1 | USE OF GDF11 TO DIAGNOSE AND TREAT ANXIETY AND DEPRESSION | Institut Pasteur (FR) | 2023-05-17 | — | — | EP | disclosed |
| US-11612639-B2 | Methods and compositions for rejuvenating skeletal muscle stem cells | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-03-28 | — | — | US | disclosed |
| EP-4140497-A1 | COMPOSITIONS FOR REJUVENATING SKELETAL MUSCLE STEM CELLS | President and Fellows of Harvard College (US) | 2023-03-01 | — | — | EP | disclosed |
| EP-2983694-B1 | COMPOSITIONS FOR REJUVENATING SKELETAL MUSCLE STEM CELLS | HARVARD COLLEGE (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2022008976-A1 | USE OF GDF11 TO DIAGNOSE AND TREAT ANXIETY AND DEPRESSION | INSTITUT PASTEUR (FR) | 2022-01-13 | — | — | WO | disclosed |
| EP-3881859-A1 | METHODS AND COMPOSITIONS FOR INCREASING NEUROGENESIS AND ANGIOGENESIS | President and Fellows of Harvard College (US) | 2021-09-22 | — | — | EP | disclosed |
| US-20160287667-A1 | METHODS AND COMPOSITIONS FOR REJUVENATING NEUROMUSCULAR JUNCTIONS | HOWARD HUGHES MEDICAL INSTITUTE | 2016-10-06 | — | — | US | disclosed |
| US-20160220640-A1 | METHODS AND COMPOSITIONS FOR INCREASING NEUROGENESIS AND ANGIOGENESIS | WAGERS, AMY JO | 2016-08-04 | — | — | US | disclosed |
| EP-3007719-A1 | METHODS AND COMPOSITIONS FOR INCREASING NEUROGENESIS AND ANGIOGENESIS | President and Fellows of Harvard College (US) | 2016-04-20 | — | — | EP | disclosed |
| US-20160074477-A1 | METHODS AND COMPOSITIONS FOR REJUVENATING SKELETAL MUSCLE STEM CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-03-17 | — | — | US | disclosed |
| EP-2983694-A2 | METHODS AND COMPOSITIONS FOR REJUVENATING SKELETAL MUSCLE STEM CELLS | President and Fellows of Harvard College (US) | 2016-02-17 | — | — | EP | disclosed |
| WO-2015070076-A2 | METHODS AND COMPOSITIONS FOR REJUVENATING NEUROMUSCULAR JUNCTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-05-14 | — | — | WO | disclosed |
| WO-2014201143-A1 | METHODS AND COMPOSITIONS FOR INCREASING NEUROGENESIS AND ANGIOGENESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-12-18 | — | — | WO | disclosed |
| WO-2014168973-A2 | METHODS AND COMPOSITIONS FOR REJUVENATING SKELETAL MUSCLE STEM CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-10-16 | — | — | WO | disclosed |
| EP-2582715-A2 | GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF | The Administrators of the Tulane Educational Fund (US) | 2013-04-24 | — | — | EP | disclosed |
| WO-2011159917-A2 | GROWTH HORMONE SECRETATOGUE RECEPTOR ANTAGONISTS AND USES THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2011-12-22 | — | — | WO | disclosed |